An interview with Ben Fioriello of the NJ Hi-Railers takes us behind the scenes in the move of an immaculate O scale layout.

The company is a speculative bet on small-scale nuclear power. The stock had been rising, but NuScale shares dropped 37% from July 25 to Aug. 19. What's going on?

10x Genomics is stepping up to buy Scale Biosciences and its single-cell profiling solutions, with plans to implement them within the company’s Chromium platform. | The deal for the recent ...

An exclusive interview with Serge Saxonov of 10x Genomics and Giovanna Prout of Scale Biosciences on what the acquisition means for single cell genomics.

BRUSSELS — NATO has started coordinating regular deliveries of large weapons packages to Ukraine after the Netherlands said it would provide air defense equipment, ammunition and other military ...

CuInS2 has emerged as a promising material for sustainable energy technologies due to its combination of attractive electronic, economic, and ecological properties. However, current synthesis routes ...

This spring the Nuclear Regulatory Commission approved a design from Oregon’s NuScale Power for a 77 megawatt nuclear reactor.

A new technical paper titled “Reduced Topography After Stop on Nitride (SON) STI CMP Through Improved Post-Bulk Planarity for Diverse Layouts in Advanced Nodes” was published by researchers at ...

Metabolic reprogramming is a notable phenotype during the acquisition of resistance to chemotherapy drugs. Thus, reverting metabolism can be an effective strategy to sensitize drug-resistant cells.

NuScale Power is looking to build small-scale modular nuclear reactors. The company has a tentative deal to sell its first reactors. In five years, the company could have operating units and a ...